ReachMD

Dr. Michael Postow is a physician on faculty at Memorial Sloan Kettering Cancer Center in the Melanoma and Immunotherapeutics Oncology Service. He completed medical school at New York University School of Medicine and internal medicine residency training at Brigham and Women’s Hospital/Harvard Medical School. He then returned to New York City to pursue a fellowship in Medical Oncology at Memorial Sloan Kettering Cancer Center where he conducts clinical research with Dr. Jedd Wolchok in melanoma and immunotherapy. He has led clinical trials involving immunotherapeutic agents, most notably a phase II study of the combination of nivolumab and ipilimumab and investigations into the combination of radiotherapy and immunotherapy. His translational efforts involve studying immunologic biomarkers associated with response to immune checkpoint inhibition. He is the Editor-In-Chief for the journal, Clinical Skin Cancer, and he also serves on the editorial board of the Journal for the Immunotherapy of Cancer. In his spare time, he enjoys playing guitar and piano, skiing, and sailing.